向细胞甲素可以抑制E型肝炎病毒的进入.
Mara Klöhn1, Thomas Burkard1, Juliana Janzen1
1Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
Hepatology (Baltimore, Md.)
|May 10, 2024
概括
阻断 lysosomal cathepsins,特别是 Cathepsin L (CTSL),有效地抑制了肝炎E病毒 (HEV) 的进入. 泛甲素抑制剂K11777显示出显著的抗HEV潜力,具有良好的安全性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
背景情况:
- 肝炎E病毒 (HEV) 导致显著的死亡率,但有效的治疗方法有限.
- 准病毒进入是抗病毒开发的一个有希望的策略.
- 宿主因子,包括细胞蛋白酶,对于病毒的进入至关重要,但对于HEV仍然不太了解.
研究的目的:
- 调查细胞蛋白酶在HEV进入中的作用.
- 评估针对HEV感染的细胞蛋白酶的治疗潜力.
主要方法:
- 利用已建立的HEV细胞培养模型和亚基因组HEV复制品.
- 采用小分子抑制剂来阻止 lysosomal cathepsins.
- 进行了添加时间和RNA范围实验.
- 生成的甲素L (CTSL) 淘汰细胞.
- 通过重组CTSL分析了HEV ORF2蛋白的裂变.
主要成果:
- 抑制 lysosomal cathepsins (CTS) 阻止了 HEV 感染,但没有影响病毒复制.
- 泛甲素抑制剂K11777表现出强大的抗HEV活性 (EC50~0.02nM),在肝瘤细胞,HepaRG和原发性人类肝细胞中具有低毒性.
- 卡瑟普辛L (CTSL) 被确定为HEV感染的关键,CTSL淘汰细胞显示了减少的容许性.
- 证实HEV的进入被阻断了由cathepsin抑制.
- 再组合的CTSL分裂了糖化HEVORF2蛋白和HEV颗粒.
结论:
- Lysosomal cathepsins,特别是 CTSL,在 HEV 进入过程中发挥着至关重要的作用.
- 泛甲素抑制剂K11777具有显著的抗HEV疗效,并且在初级细胞中具有良好的安全性,这表明其具有治疗潜力.
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


